GFAI - HUYA SPPI and DOYU among pre market gainers

Veru (VERU) +31% after interim results for COVID-19 therapy. SailPoint Technologies (SAIL) +30% acquisition could lead to other cyber security deals, Wedbush says. Iveda Solutions (IVDA) +28%. VNET Group (VNET) +20% receives buyout offer of $1.3333 per share. Affimed (AFMD) +13% after data on blood cancer therapy from phase 1/2 study. Axcella Health (AXLA) +13%. AIM ImmunoTech (AIM) +11% positive data for Ampligen from two cancer trials. Eton Pharmaceuticals (ETON) +11% on FDA approval for Elcys generic. Spectrum Pharmaceuticals (SPPI) +9% announces FDA acceptance of BLA Resubmission for Eflapegrastim. 4D pharma (LBPS) +9%. NetEase (NTES) +8%, Bilibili surge as China to restart approving game licenses: report Bilibili (BILI) +8% as China to restart approving game licenses: report HUYA (HUYA) +8%. Frequency Therapeutics (FREQ) +8%. Guardforce AI (GFAI) +8%. GDS Holdings (GDS) +7%. Hycroft Mining Holding (HYMC) +7% announces new board appointments. DouYu International (DOYU) +6%. Chindata Group (CD) +6%. Hudson Capital (HUSN) +5%.

For further details see:

HUYA, SPPI and DOYU among pre market gainers